Healthcare & Pharmaceuticals Conferences

Get RSS Get by Email Submit Event Submit News

Mayo Clinic Updates in Internal Medicine 2018

Date: 18-Oct-18 to 21-Oct-18
Location: United States
Updates in Internal Medicine will present up-to-date information as well as contemporary approaches/strategies to the ever-changing and expanding discipline of internal medicine. The program will attempt to cover the scope of internal medicine, selecting from a variety of pertinent general and sub-specialty derived topics. Expert faculty will present evidence-based and emerging practical clinical approaches, regarding various general and sub-specialty topics. OPTIONAL: ABIM MOC Learning Modules on Wednesday, October 17, 2018. LEARNING OBJECTIVES Upon completion of this activity, participants should be able to: 1 – Summarize recent updates, clinical studies, and new guidelines that impact practice in general medicine 2 – Describe updates in direct oral anticoagulant management 3 – ...

OmniaMed Kongress-Highlights Diabetologie Köln 2018

Date: 20-Oct-18 to 21-Oct-18
Location: Germany
Diabetologie 2018: Viele Studien, nationale und internationale Diabeteskongresse und gesundheitspolitische Diskussionen, aber was ändert sich in der klinischen Praxis für die uns anvertrauten Patienten? Das ist der Fokus dieser Fortbildung, in der wir die Neuigkeiten des Jahres für die klinische Praxis bei häufigen und relevanten Themen zusammenfassen. Ziel ist es, die praktische Relevanz herauszuarbeiten und mit Ihnen zusammen zu diskutieren. Die Kernfrage dieser Veranstaltung ist nicht, was ist neu, sondern: Was ändert unser ärztliches Handeln? - Topaktuelle Inhalte von den - Geeignet für Diabetologen, Internisten, Allgemeinmediziner und Assistenzä - Ausgewiesene Experten als - Konsequente Ausrichtung auf den Praxis-/ - Viel Raum für ...

Immune Checkpoint Inhibitors in the Treatment of Stage III NSCLC, Oct 23

Date: 23-Oct-18 to 23-Oct-18
Location: Orlando / United States
Join us on Tuesday, October 23 at the Orlando World Center Marriott for a clinic-focused symposium during AMCP Nexus 2018. Explore the pharmacist’s critical role in the optimal integration of checkpoint inhibitors into the care of patients with unresectable stage III NSCLC at this dynamic satellite. Attendees will have the opportunity to text questions to expert faculty, Ali McBride, PharmD, MS, BCOP, FAzPA; Sandra Cuellar, PharmD, BCOP; and Tarek M. Mekhail, MD, MSc, FRCSI, FRCSEd, and get practical guidance on the application of immunotherapy approaches to early-stage NSCLC. This satellite symposium is complimentary to attend and is ACPE-certified for 1.5 contact hours. For more information and to register, go to https://events.clinicaloptions.com/oncology/Nexus2018.

Assessing RET-Altered Tumors for Personalized Oncology Care, Oct 23

Date: 23-Oct-18 to 23-Oct-18
Location: Chicago / United States
Join us on Tuesday, October 23 at the Hyatt Regency in Chicago for a dynamic symposium during CAP 2018. Learn about the latest clinical data on selective RET inhibitors along with practical guidance to facilitate the detection of RET alterations from leading pathology experts, Dara L. Aisner, MD, PhD, and Eric Q. Konnick, MD, MS. They will lead discussions and answer your questions on the methodology and testing strategies for RET fusions and mutations.. This satellite symposium is complimentary to attend and is CME-certified for 1.5 contact hours.

National Family Medicine Board Review

Date: 21-Oct-18 to 24-Oct-18
Location: Las Vegas / United States
The National Family Medicine Board Review course is a four-day, 33-hour total immersion “boot-camp” in the factual database of family medicine. The goal of the course to help participants pass their exams—drives the content. At the conclusion, participants, through repetition, will have learned the key information needed to pass family medicine certification and recertification examinations. The target audience is physicians planning to take the certification or recertification exam of the American Board of Family Medicine, and other clinicians wishing a comprehensive review of the specialty of Family Medicine. After attending this course, participants will be able to: Identify the fundamental concepts and key topics needed to successfully complete the Family Medicine written ...

92nd Annual Clinical Reviews 2018

Date: 22-Oct-18 to 24-Oct-18
Location: Rochester / United States
This course is offered twice, October 22-24 and again November 5-7. This course is designed for physicians, nurse practitioners, physician assistants and nurses practicing in primary care, family medicine and internal medicine. Course Highlights: -Concise didactic -Content focused on the needs of the primary care provider in the clinical -Dedicated question and answer sessions throughout the -Pre-course ABFM Knowledge Self- -Breakout sessions for personalized course -Course app containing all presentations with note-taking Learning Objectives: Upon conclusion of this program, participants should be able to: -Formulate new treatment options for the management of patients with poorly controlled type 2 diabetes -...

2nd Annual NASH Summit Europe

Date: 22-Oct-18 to 24-Oct-18
Location: Frankfurt / Germany
Built from research with the FDA, EMA and Gilead, the 2nd Annual NASH Summit Europe will once again elevate industry-to-industry dialogue and reveal leading insights in overcoming the hurdles limiting NASH therapeutic success. Join the NASH community as they collectively address the biggest challenges in NASH through a tighter lens including the potential for stand-alone versus combination therapeutics, the genetic drivers influencing disease heterogeneity and the future payer and reimbursement landscape. Hear from 22 stakeholders including Pfizer, Novartis and MedImmune as this exclusively drug development driven forum equips you with the connections and actionable takeaways you need to capture one of many market opportunities for a successful NASH candidate.

Gene Therapy for Rare Disorders Europe Summit

Date: 22-Oct-18 to 24-Oct-18
Location: United Kingdom
Dedicated to Realizing the Commercial Potential of Gene Now is a crucial time for the gene therapy field, as the ripple effects of the pioneering first US gene therapy approval are being felt globally, setting new benchmarks and posing unexpected questions. Rather than early stage basic science, the Gene Therapy for Rare Disorders Europe Conference is solely devoted to addressing the latest clinical, manufacturing, regulatory and commercialization challenges facing this rapidly evolving field. This is a comprehensive guide to define your commercial path forward. Here’s a snapshot of the companies who attended last year: Pfizer – Shire – Lysogene – BioMarin – Novasep – Horama – Orchard Therapeutics – Avrobio – Genzyme – Astellas – uniQure – Syneos Health – REGENXBIO – Chiesi – ...

Genotoxic Impurities

Date: 23-Oct-18 to 24-Oct-18
Location: Berlin / Germany
The brightest industry and regulatory minds shine a light on identification and control of GTIs. Build a complete strategy for potential genotoxic impurities in your pharmaceuticals.

Precision CRISPR: Drug Discovery and Gene Therapy London 2018

Date: 22-Oct-18 to 24-Oct-18
Location: United Kingdom
Precision CRISPR: Drug Development & Gene Therapy Congress returns for the 3rd time, just in time to face the building excitement in getting CRISPR gene therapy into the clinic. Take a look at the conference program and engage with this community today: https://bit.ly/ Through a dynamic program of focused sessions, interactive discussions and networking opportunities, you will leave this meeting with a deep understanding of: - the challenges in delivery & reducing off-target effects in ex vivo & in vivo gene - how the likes of GSK, Novartis, AstraZeneca and more, work towards improving the efficacy of functional screening and drug - the most recent gene editing techniques and Cas variants poised to make precise gene editing all that more ...